Serum albumin and risk of stroke, coronary heart disease, and mortality: The role of cigarette smoking

Journal of Clinical Epidemiology

Volumn 57, Issue 2, 2004, Pages 195-202

  Shaper, A Gerald ^a,c   Wannamethee, S Goya ^a   Whincup, Peter H ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c The Ridgeway ^*  (United Kingdom)

Author keywords

Coronary heart disease; Mortality; Serum albumin; Smoking; Stroke

Indexed keywords

ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; STROKE; UNITED KINGDOM;

EID: 2442651392     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2003.07.001     Document Type: Article

References (30)

1. Phillips A., Shaper A.G., Whincup P.H. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet. 2:1989;1434-1436
2. Kuller L.H., Eichner J.E., Orchard T.J., Grandits G.A., McCallum L., Tracy R.P. The relation between albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 134:1991;1266-1277
3. Gillum R.F., Makuc D.M. Serum albumin, coronary heart disease and death. Am Heart J. 123:1992;507-513
4. Klonoff-Cohen H., Barrett-Connor E.L., Edelstein S.L. Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol. 45:1992;207-212
5. Corti M., Guralnik J.M., Salive M.E., Sorkin J.D. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 272:1994;1036-1042
6. Luoma P.V., Nayha S., Sikkila K., Hassi J. High serum alpha-tocopherol, albumin, selinium and cholesterol and low mortality from coronary heart disease in Northern Finland. J Intern Med. 237:1995;49-54
7. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol. 144:1996;537-547
8. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive Protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 279:1998;1477-1482
9. Gillum R.F., Ingram D.D., Makuc D.M. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 140:1994;876-888
10. Goldwasser P., Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 45:1992;207-212
11. Gillum R.F. Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and Whites. J Natl Med Assoc. 92:2000;3-9
12. Nelson J.J., Liao D., Sharrett A., Folsom A.R., Chambless L.E., Shahar E., Szklo M., Eckfeld J., Heiss G. Serum albumin level as a predictor of incident coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 151:2000;468-477
13. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta. 153:1985;9-13
14. Salive M.E., Cornoni-Huntley J., Phillips C.L., Guralnik J.M., Cohen H.J., Ostfeld A.M., Wallace R.B. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol. 45:1992;213-221
15. Shaper A.G., Pocock S.J., Walker M., Cohen N.M., Wale C.J., Thomson A.G. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 283:1981;179-186
16. Bruce N.G., Shaper A.G., Walker M., Wannamethee G. Observer bias in blood pressure studies. J Hypertens. 6:1988;374-380
17. Thelle D.S., Shaper A.G., Whitehead T.P., Bullock D.G., Ashby D., Patel I. Blood lipids in middle-aged British men. Br Heart J. 49:1983;205-213
18. Shaper A.G., Wannamethee G., Walker M. Alcohol and mortality: explaining the U-shaped curve. Lancet. ii:1988;1268-1273
19. Shaper A.G., Wannamethee G., Weatherall R. Physical activity and ischaemic heart disease in middle-aged men. Br Heart J. 66:1991;384-394
20. Cook D.G., Shaper A.G., Macfarlane P.W. Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology studies. Int J Epidemiol. 18:1989;607-613
21. Phillips A.N., Shaper A.G., Pocock S.J., Walker M., Macfarlane P.W. The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease. Br Heart J. 60:1988;404-410
22. Shaper A.G., Cook D.G., Walker M., Macfarlane P.W. Prevalence of ischaemic heart disease in middle-aged British men. Br Heart J. 51:1984;595-605
23. Walker M., Shaper A.G., Lennon L., Whincup P.H. Twenty year follow-up of a cohort based in general practice in 24 British towns. J Public Health Med. 22:2000;479-485
24. Shaper A.G., Pocock S.J., Walker M., Phillips A.N., Whitehead T.P., Macfarlane P.W. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health. 39:1985;197-209
25. Cox D.R. Regression models and life tables (with discussion). J R Stat Soc B. 34:1972;187-220
26. Law M.R., Morris J.K., Wald N.J., Hale A.K. Serum albumin and mortality in the BUPA Study. Int J Epidemiol. 23:1994;38-41
27. Danesh J., Muir J., Wong Y.K., Ward M., Gallimore J.R., Pepys M.B. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J. 20:1999;954-959
28. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126
29. Whitehead T.P., Robinson D., Allaway S.L. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem. 33:1996;530-535
30. Waranabe K., Eto K., Furuno K., Mori K., Kawasaki H., Gomita Y. Effect of cigarette smoking on lipid peroxidation and liver function tests. Acta Med Okayama. 49:1995;271-274